News in the Life Sciences Industry

Anderson Regional Cancer Center in Meridian, Mississippi, U.S., has treated its first patient using the combination of RaySearch's treatment planning system (TPS) RayStation, and Accuray Incorporated's TomoTherapy® Treatment Delivery System. This is the first-ever treatment in the U.S. using... Read more ››

STOCKHOLM, March 7, 2019 /PRNewswire/ -- Neonode Inc. (NASDAQ: NEON), the Optical Interactive Sensing Technology Company, today reported financial results for the fourth quarter and year ended December 31, 2018.

STOCKHOLM, March 7, 2019 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) informs that Eisai today announced the timelines for the single confirmatory Phase 3 study with BAN2401 in early Alzheimer´s disease patients i.e. mild cognitive impairment due to Alzheimer's disease or mild... Read more ››

LUND, Sweden, March 7, 2019 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces that the first patient has successfully been dosed in its phase I study of ATOR-1015, its drug candidate in development for tumor-directed immunotherapy. ATOR-1015 is designed with... Read more ››

STOCKHOLM, March 6, 2019 /PRNewswire/ -- RayStation was the selected treatment planning system in 2017, when the proton therapy center was established. ZON-PTC is a joint undertaking between MAASTRO clinic and the Maastricht University Medical Center (Maastricht UMC+). The center opened early... Read more ››

LUND, Sweden, March 6, 2019 /PRNewswire/ -- Hansa Biopharma AB (NASDAQ Stockholm: HNSA), the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, announced today that Søren Tulstrup, President and CEO of Hansa Biopharma, will present at the Cowen 39th Annual Health... Read more ››

UPPSALA, Sweden, March 5, 2019 /PRNewswire/ -- The shareholders in Orexo AB (publ), reg. no. 556500-0600, registered office Uppsala, are summoned to the annual general meeting, to be held on Thursday 11 April 2019, at 4.00 pm in Orexo's facilities at Virdings allé 32A, in Uppsala, Sweden.

TAIPEI, Taiwan and TOKYO, March 5, 2019 /PRNewswire/ -- Health2Sync and Novo Nordisk Pharma Ltd. are partnering in Japan to support digital diabetes management and facilitate communication between diabetics and healthcare providers. Last December, the two companies agreed to support the localization... Read more ››